Ref.: BL-RE-155213Manufacturer ref.: EM18RBX5 5 x 96 tests
€2,950.00 excl. VAT
Mouse Clusterin quantitates mouse Clusterin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Clusterin.
Accession number
AAG4 ; protéine génétique 4 associée au vieillissement ; protéine 4 associée au vieillissement ; AI893575 ; apo j ; Apo J a ; Apo J alpha ; Apo J b ; Apo J beta ; Apo J a ; Apo J ß ; Apo Ja ; Apo Jb ; APOJ ; APO-J ; ApoJ a ; ApoJ alpha ; ApoJ b ; ApoJ bêta ; ApoJ a ; ApoJ ß ; ApoJa ; ApoJalpha ; ApoJb ; ApoJbeta ; Apolipoprotéine J ; CLI ; CLU ; CLU1 ; CLU2 ; clusterine ; chaîne alpha de la clusterine ; chaîne bêta de la clusterine ; clusterine ; inhibiteur de cytolyse complémentaire ; chaine a d’inhibiteur de cytolyse complémentaire ; chaine b d’inhibiteur de cytolyse complémentaire ; inhibiteur de lyse complémentaire ; protéine associée au complément SP-40,40 ; D14Ucla3 ; DAG ; glycoprotéine acide dimère ; HGNC:2095 ; protéine de liaison de ku70 1 ; KUB1 ; MGC24903 ; Msgp-2 ; NA1/NA2 ; RATTRPM2B ; SGP2 ; SGP-2 ; SP40 ; SP-40 ; Suggp-2 ; glycoprotéine
Dose range
0.1 to 24 ng/ml
Sensitivity of the dosage
0.1 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Mouse Clusterin quantitates mouse Clusterin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Clusterin.
Mouse Clusterin quantitates mouse Clusterin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Clusterin.
The isoform 1 works as an extracellular chaperone that prevents the aggregation of non-native proteins. Prevents aggregation induced by stress of blood plasma proteins. Inhibits the formation of amyloid fibrils by variants APP, APOC2, B2M, CALCA, CSN3, SNCA and Lyz (in vitro), subject to aggregation. Does not require ATP. Maintains partially unfolded proteins in an appropriate state for subsequent revoltage by other chaperons, such as HSPA8/HSC70. Don't rebut proteins per se. The binding to cell surface receptors triggers the internalization of the client-chaperon complex and subsequent lysosome or proteosomal degradation. The secreted L-isoform protects the cells against L-apoptosis and from cytolysis by complement. Intracellular isoforms interact with the complexes of diubiquitin and FCS (protein SKP1-CUL1-F-box) E3 ubiquitin-protein ligase and promote ubiquitination and subsequent protein degradation of the target proteins. Promotes proteosomal degradation of COMMD1 and IKBKB. Module of transcriptional activity NF-kappa-B. Nuclear isoforms promote apoptosis. Mitochondrial isoforms inhibit the release of BAX-dependent cytochrome c into the cytoplasm and inhibit the apoptosis. Plays a role in regulating cell proliferation.
Sensitivity
Sensitivity of dosage: 0.1 ng/ml.
Measurement range
Dose range: 0.1 to 24 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Apolipoprotein J.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17105619
Specifications
Accession number
AAG4; genetic protein 4 associated with aging; protein 4 associated with aging; AI893575 ; apo j ; Apo J a; Apo J alpha; Apo J b; Apo J beta; Apo J a; Apo J ß; Apo Ja; Apo Jb; APOJ; APO-J; ApoJ a; ApoJ alpha; ApoJ b; ApoJ beta; ApoJ a; ApoJ ß; ApoJa; ApoJalpha; Apo